Home > Insider Trading > Filing (0001439222-22-000009)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1439222	Agios Pharmaceuticals Inc.	AGIO	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1874199	Jr. James Theodore Washburn	88 Sidney Street Cambridge MA 02139	Principal Accounting Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2022-02-14	360	$0.00	3,413	No	4	M	Direct
Common Stock	Disposition	2022-02-14	127	$30.50	3,286	No	4	F	Direct
Common Stock	Disposition	2022-02-14	504	$31.25	2,782	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	F	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted stock units	Disposition	2022-02-14	360	$0.00	360	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
360			No	4	M	Direct

Footnotes

Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
Includes 34 shares purchased through the Company's employee stock purchase plan.
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The restricted stock units were granted on February 14, 2020. Beginning on February 14, 2021, the shares underlying the restricted stock units will vest in three equal annual installments.